Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06335771

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity-Associated Diseases

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Bettina Mittendorfer · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to evaluate the role of transcription factor EB (TFEB) in adipose (fat) tissue macrophages (ATM) in regulating adipose tissue and systemic metabolic function in obesity. The investigators will assess the differences in ATM lipid metabolism in people with metabolically abnormal obesity and lean individuals. Both groups will have: * screening visit * imaging (body composition testing - dual-energy x-ray absorptiometry (DEXA) scans, magnetic resonance imaging \[MRI\] and magnetic resonance spectroscopy \[MRS\] scans) * Overnight visit with intravenous infusion (IV), muscle, and fat tissue biopsies Participants with obesity will complete meetings with study team members for a weight loss intervention to achieve a 10% body weight loss.

Conditions

Interventions

TypeNameDescription
OTHERDietary consultation weight loss interventionParticipants will meet with a member of the study team biweekly for about 6 months.

Timeline

Start date
2024-08-01
Primary completion
2028-03-01
Completion
2028-03-01
First posted
2024-03-28
Last updated
2025-07-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06335771. Inclusion in this directory is not an endorsement.